September 18, 2014 8:17 PM ET

Pharmaceuticals

Company Overview of Jennerex Biotherapeutics, Inc.

Executive Profile

Glen Y. Sato J.D., M.B.A.

AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships
55--

Background

Mr. Glen Y. Sato, J.D., M.B.A. serves as Secretary of Anacor Pharmaceuticals, Inc. Mr. Sato serves as Corporate Counsel of Jennerex Biotherapeutics, Inc. Mr. Sato is a Partner of Cooley Godward Kronish LLP and joined it in 2006. Mr. Sato has significant experience with SEC reporting and compliance, disclosure issues, intellectual property licensing and Licensing Strategy, General Corporate Counseling, Insider Trading Compliance and Intellectual Property Protection. Mr. ...

Corporate Headquarters

450 Sansome Street
San Francisco, California 94111

United States

Phone: 415-281-8886
Fax: --

Board Members Memberships

Director
Corporate Counsel and Director
2004-Present
Director
2009-Present
Lead Independent Director, Chairman of Audit Committee and Chairman of Compensation Committee

Education

JD
University of California-Los Angeles
MBA
University of California-Los Angeles
BA
Wesleyan University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Jennerex Biotherapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.